苯丙胺过量

Carvalho M, Carmo H, Costa VM, et al. Toxicity of amphetamines: an update. Arch Toxicol. 2012;86:1167-1231.

• 摘要

Glasner-Edwards S, Mooney LJ. Methamphetamine psychosis: epidemiology and management. CNS Drugs. 2014;28:1115-1126.

• 全文
• 摘要

Richards JR, Albertson TE, Derlet RW, et al. Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015;150:1-13.

• 摘要

Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96:635-642.

• 全文
• 摘要

Sliman S, Waalen J, Shaw D. Methamphetamine-associated congestive heart failure: increasing prevalence and relationship of clinical outcomes to continued use or abstinence. Cardiovasc Toxicol. 2016;16:381-389.

• 摘要

Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group (2017) Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health

• 全文

National Institute for Health and Care Excellence. Drug use disorders in adults (Quality Standard QS23). November 2012. http://www.nice.org.uk/ (last accessed 24 May 2017).

• 全文

1.  Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289:2983-2991.

• 全文
• 摘要

2.  Moon K, Albuquerque FC, Mitkov M, et al. Methamphetamine use is an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurointerv Surg. 2015;7:346-350.

• 摘要

3.  Gledhill JA, Moore DF, Bell D, et al. Subarachnoid haemorrhage associated with MDMA abuse. J Neurol Neurosurg Psychiatry. 1993;56:1036-1037.

• 摘要

4.  Bowyer JF, Hanig JP. Amphetamine- and methamphetamine-induced hyperthermia: implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity. Temperature (Austin). 2014;1:172-182.

• 全文
• 摘要

5.  Matsumoto RR, Seminerio MJ, Turner RC, et al. Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia. Pharmacol Ther. 2014;144:28-40.

• 全文
• 摘要

6.  Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: results from the 2015 National Survey on Drug Use and Health. September 2016. https://www.samhsa.gov/ (last accessed 25 May 2017).

• 全文

7.  Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ. 2001;165:917-928.

• 全文
• 摘要

8.  Hall AP, Henry JA. Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth. 2006;96:678-685.

• 全文
• 摘要

9.  Carvalho M, Carmo H, Costa VM, et al. Toxicity of amphetamines: an update. Arch Toxicol. 2012;86:1167-1231.

• 摘要

10.  Harro J. Neuropsychiatric adverse effects of amphetamine and methamphetamine. Int Rev Neurobiol. 2015;120:179-204.

• 摘要

11.  United Nations Office on Drugs and Crime. World Drug Report 2016. May 2016. http://www.unodc.org/ (last accessed 24 May 2017).

• 全文

12.  United Nations Office on Drugs and Crime. 2014 global synthetic drugs assessment: amphetamine-type stimulants and new psychoactive substances. May 2014. http://www.unodc.org/ (last accessed 24 May 2017).

• 全文

13.  Substance Abuse and Mental Health Services Admnistration (SAMHSA), Drug Abuse Warning Network (DAWN) report. Emergency department visits involving methamphetamine: 2007 to 2011. June 2014. https://www.samhsa.gov/ (last accessed 24 May 2017).

• 全文

14.  Fleckenstein AE, Volz TJ, Riddle EL, et al. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007;47:681-698.

• 摘要

15.  Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. 2014;143:11-21.

• 全文
• 摘要

16.  Yamamoto T, Malavasi E, Archer JR, et al. Management of body stuffers presenting to the emergency department. Eur J Emerg Med. 2016;23:425-429.

• 摘要

17.  Liechti ME, Kunz I, Kupferschmidt H. Acute medical problems due to Ecstasy use: case-series of emergency department visits. Swiss Med Wkly. 2005;135:652-657.

• 全文
• 摘要

18.  Tossmann P, Boldt S, Tensil MD. The use of drugs within the techno party scene in European metropolitan cities. Eur Addict Res. 2001;7:2-23.

• 摘要

19.  Barrett SP, Darredeau C, Pihl RO. Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol. 2006;21:255-263.

• 摘要

20.  Liechti M. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. Swiss Med Wkly. 2015;145:w14043.

• 全文
• 摘要

21.  Schep LJ, Slaughter RJ, Beasley DM. The clinical toxicology of metamfetamine. Clin Toxicol (Phila). 2010;48:675-694.

• 摘要

22.  Hutson PH, Tarazi FI, Madhoo M, et al. Preclinical pharmacology of amphetamine: implications for the treatment of neuropsychiatric disorders. Pharmacol Ther. 2014;143:253-264.

• 摘要

23.  Richards JR, Johnson EB, Stark RW, et al. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am J Emerg Med. 1999;17:681-685.

• 摘要

24.  Kaye S, Darke S, Duflou J, et al. Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Addiction. 2008;103:1353-1360.

• 摘要

25.  Schifano F, Corkery J, Naidoo V, et al. Overview of amphetamine-type stimulant mortality data - UK, 1997-2007. Neuropsychobiology. 2010;61:122-130.

• 摘要

26.  Bordo DJ, Dorfman MA. Ecstasy overdose: rapid cooling leads to successful outcome. Am J Emerg Med. 2004;22:326-327.

• 摘要

27.  Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013;25:193-199.

• 摘要

28.  Poikolainen K. Ecstasy and the antecedents of illicit drug use. BMJ. 2006;332:803-804.

• 摘要

29.  Russell K, Dryden DM, Liang Y, et al. Risk factors for methamphetamine use in youth: a systematic review. BMC Pediatr. 2008;8:48.

• 全文
• 摘要

30.  Faraone SV, Wilens TE. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. J Clin Psychiatry. 2007;68(suppl 11):15S-22S.

• 摘要

31.  Cumming C, Troeung L, Young JT, et al. Barriers to accessing methamphetamine treatment: a systematic review and meta-analysis. Drug Alcohol Depend. 2016;168:263-273.

• 摘要

32.  Tucker GT, Lennard MS, Ellis SW, et al. The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol. 1994;47:1151-1156.

• 摘要

33.  Maurer HH, Kraemer T, Springer D, et al. Chemistry pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Ther Drug Monit. 2004;26:127-131.

• 摘要

34.  Kraemer T, Maurer HH. Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives. Ther Drug Monit. 2002;24:277-289.

• 摘要

35.  Sutter ME, Gaedigk A, Albertson TE, et al. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure. Clin Toxicol (Phila). 2013;51:540-544.

• 摘要

36.  Glasner-Edwards S, Mooney LJ. Methamphetamine psychosis: epidemiology and management. CNS Drugs. 2014;28:1115-1126.

• 全文
• 摘要

37.  Richards JR, Albertson TE, Derlet RW, et al. Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015;150:1-13.

• 摘要

38.  Armenian P, Mamantov TM, Tsutaoka BT, et al. Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. J Intensive Care Med. 2013;28:252-258.

• 摘要

39.  Yacoubian GS Jr, Peters RJ. An exploration of recent club drug use among rave attendees. J Drug Educ. 2007;37:145-161.

• 摘要

40.  Fendrich M, Wislar JS, Johnson TP, et al. A contextual profile of club drug use among adults in Chicago. Addiction. 2003;98:1693-1703.

• 摘要

41.  De-Carolis C, Boyd GA, Mancinelli L, et al. Methamphetamine abuse and "meth mouth" in Europe. Med Oral Patol Oral Cir Bucal. 2015;20:e205-e210.

• 全文
• 摘要

42.  Richards JR, Brofeldt BT. Patterns of tooth wear associated with methamphetamine use. J Periodontol. 2000;71:1371-1374.

• 摘要

43.  Degenhardt L, Coffey C, Carlin JB, et al. Who are the new amphetamine users? A 10-year prospective study of young Australians. Addiction. 2007;102:1269-1279.

• 摘要

44.  Sterk CE, Theall KP, Elifson KW. Getting into ecstasy: comparing moderate and heavy young adult users. J Psychoactive Drugs. 2007;39:103-113.

• 摘要

45.  Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96:635-642.

• 全文
• 摘要

46.  Suarez RV, Riemersma R. "Ecstasy" and sudden cardiac death. Am J Forensic Med Pathol. 1988;9:339-341.

• 摘要

47.  Turnipseed SD, Richards JR, Kirk JD, et al. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med. 2003;24:369-373.

• 摘要

48.  Johnson TD, Berenson MM. Methamphetamine-induced ischemic colitis. J Clin Gastroenterol. 1991;13:687-689.

• 摘要

49.  Baggott MJ. Preventing problems in Ecstasy users: reduce use to reduce harm. J Psychoactive Drugs. 2002;34:145-162.

• 摘要

50.  Jafari Giv M. Exposure to amphetamines leads to development of amphetamine type stimulants associated cardiomyopathy (ATSAC). Cardiovasc Toxicol. 2017;17:13-24.

• 摘要

51.  Sliman S, Waalen J, Shaw D. Methamphetamine-associated congestive heart failure: increasing prevalence and relationship of clinical outcomes to continued use or abstinence. Cardiovasc Toxicol. 2016;16:381-389.

• 摘要

52.  Won S, Hong RA, Shohet RV, et al. Methamphetamine-associated cardiomyopathy. Clin Cardiol. 2013;36:737-742.

• 全文
• 摘要

53.  Akhgari M, Mobaraki H, Etemadi-Aleagha A. Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths. Daru. 2017;25:5.

• 全文
• 摘要

54.  Jones AL, Dargan PI. Churchill's textbook of toxicology. Edinburgh, UK: Churchill-Livingstone; 2001.

55.  Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group (2017) Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health

• 全文

56.  College of Emergency Medicine. Caring for adult patients suspected of having concealed illicit drugs. June 2014. https://www.rcem.ac.uk/ (last accessed 24 May 2017).

• 全文

57.  Shoptaw, SJ, Kao U, Ling W. Treatment for amphetamine psychosis. Cochrane Database Syst Rev. 2009;(1):CD003026.

• 摘要

58.  London JA, Utter GH, Battistella F, et al. Methamphetamine use is associated with increased hospital resource consumption among minimally injured trauma patients. J Trauma. 2009;66:485-490.

• 摘要

59.  Richards JR, Derlet RW, Albertson TE, et al. Methamphetamine, "bath salts," and other amphetamine-related derivatives: progressive treatment update. August 2014. http://www.enlivenarchive.org/ (last accessed 24 May 2017).

• 全文

60.  Radfar SR, Rawson RA. Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts. Addict Health. 2014;6:146-154.

• 全文
• 摘要

61.  Asser A, Taba P. Psychostimulants and movement disorders. Front Neurol. 2015;6:75.

• 全文
• 摘要

62.  Cassel JC, Hamida SB, Jones BC. Ethanol and MDMA: a comment on the paper by Dumont et al. Psychopharmacology (Berl). 2008;200:305-306.

• 摘要

63.  U.S. Preventive Services Task Force. Screening for illicit drug use: recommendation statement. AHRQ Publication No. 08-05108-EF-3. 2008. http://www.uspreventiveservicestaskforce.org/ (last accessed 24 May 2017).

• 全文

64.  Canadian Agency for Drugs and Technologies in Health. Use of antipsychotics and/or benzodiazepines as rapid tranquilization in in-patients of mental facilities and emergency departments: a review of the clinical effectiveness and guidelines. October 2015. https://www.cadth.ca/ (last accessed 15 May 2017).

• 全文

65.  Calver L, Drinkwater V, Gupta R, et al. Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: randomised controlled trial. Br J Psychiatry. 2015;206:223-228.

• 全文

66.  Yap CY, Taylor DM, Knott JC, et al. Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial. Addiction. 2017 Feb 4 [Epub ahead of print].

• 摘要

67.  Taylor DM, Yap CY, Knott JC, et al. Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial. Ann Emerg Med. 2017;69:318-326.

• 摘要

68.  Chan EW, Taylor DM, Knott JC, et al. Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Ann Emerg Med. 2013;61:72-81.

• 摘要

69.  Richards JR, Schneir AB. Droperidol in the emergency department: is it safe? J Emerg Med. 2003;24:441-447.

• 摘要

70.  Perkins J, Ho JD, Vilke GM, et al. American Academy of Emergency Medicine position statement: safety of droperidol use in the emergency department. J Emerg Med. 2015;49:91-97.

• 摘要

71.  O'Connor AD, Padilla-Jones A, Gerkin RD, et al. Prevalence of rhabdomyolysis in sympathomimetic toxicity: a comparison of stimulants. J Med Toxicol. 2015;11:195-200.

• 全文
• 摘要

72.  Richards JR, Colby DK. Stimulant-induced hyperthermia and ice-water submersion: practical considerations. Clin Toxicol (Phila). 2016;54:69-70.

• 摘要

73.  Li J, Li J, Chen Y, et al. Methamphetamine use associated with monomorphic ventricular tachycardia. J Addict Med. 2014;8:470-473.

• 摘要

74.  Haning W, Goebert D. Electrocardiographic abnormalities in methamphetamine abusers. Addiction. 2007;102(suppl 1):70-75.

• 摘要

75.  Etminan N, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage. Handb Clin Neurol. 2017;140:195-228.

• 摘要

76.  Grunau BE, Wiens MO, Brubacher JR. Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review. CJEM. 2010;12:435-442.

• 摘要

77.  Kram B, Kram SJ, Sharpe ML, et al. Analgesia and sedation requirements in mechanically ventilated trauma patients with acute, preinjury use of cocaine and/or amphetamines. Anesth Analg. 2017;124:782-788.

• 摘要

78.  Verheyden SL, Henry JA, Curran HV. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users. Hum Psychopharmacol. 2003;18:507-517.

• 摘要

79.  Rogers G, Elston J, Garside R, et al. The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health Technol Assess. 2009;13:iii-iv,ix-xii,1-315.

• 摘要

80.  Jones AL, Simpson KJ. Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment Pharmacol Ther. 1999;13:129-133.

• 全文
• 摘要

81.  Mizia-Stec K, Gasior Z, Wojnicz R, et al. Severe dilated cardiomyopathy as a consequence of Ecstasy intake. Cardiovasc Pathol. 2008;17:250-253.

• 摘要

82.  Marsh JC, Abboudi ZH, Gibson FM, et al. Aplastic anaemia following exposure to 3,4-methylendioxymethamphetamine ('Ecstasy'). Br J Haematol. 1994;88:281-285.

• 摘要

83.  Whitlock EP, Orleans CT, Pender N, et al. Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med. 2002;22:267-284.

• 摘要

84.  National Institute for Health and Care Excellence. Drug use disorders in adults (Quality Standard QS23). November 2012. http://www.nice.org.uk/ (last accessed 24 May 2017).

• 全文

85.  Davidson C. Developing treatments for stimulant abuse: a brief overview. East Asian Arch Psychiatry. 2016;26:52-59.

• 全文
• 摘要